AdenosINe Sestamibi Post-InfaRction Evaluation (INSPIRE) Trial - INSPIRE


The goals of the INSPIRE trial were to evaluate: 1) the degree to which the detection of scintigraphic ischemia tracks prognosis, and 2) whether maximal medical therapy is as effective as coronary revascularization for reducing ischemia and improving outcome in a randomized subset of high-risk patients with myocardial infarction (MI).